Castle Biosciences Inc. has granted restricted stock units (RSUs) to 83 employees, covering a total of 139,494 shares of common stock. The RSUs will vest over four years, with 25% of the shares vesting on the first anniversary of the vesting commencement date and the remaining shares vesting in three equal annual installments, contingent on continued employment.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Castle Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9602310-en) on December 19, 2025, and is solely responsible for the information contained therein.
Comments